Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

Federal Circuit Considers Patentability of Overlapping Ranges

16 May 2023, 7:51 am by Yogeeta B. Jadhav and Courtenay C. Brinckerhoff

In UCB Inc. v. [read post]

PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents

Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2022)

14 Jul 2022, 9:55 pm by Patent Docs

Noonan -- Almost four years ago, in a relatively rare occurrence based on there being an insufficient factual record to permit proper appellate review, the Federal Circuit vacated a District Court decision rendering invalid the claims in five patents asserted by Tris Pharma, Inc. against Teva Laboratories FL, Inc. and remanded. [read post]

Patent Docs - http://www.patentdocs.org/

Reasonable Expectation of Success as the Post-KSR Nonobviousness Hook

8 Jul 2022, 3:47 am by Dennis Crouch

Tris Pharma, Inc. v. [read post]

Patently-O - https://patentlyo.com

Despite Setbacks in Court, California’s Ban on Pharmaceutical Pay-For-Deals Could Still Recover

24 Mar 2022, 12:04 pm by Zak Gowen

Actavis, Inc., 570 U.S. 136 (2013), which held that such payments are unlawful when they are “large and unjustified. [read post]

Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/

Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2019)

20 Aug 2019, 9:59 pm by Patent Docs

Actavis Laboratories FL, Inc. [read post]

Patent Docs - http://www.patentdocs.org/

Never too late: if you missed the IPKat last week

16 Jun 2019, 11:07 am

A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]

IPKat - http://ipkitten.blogspot.com/

Never Too Late: If you missed the IPKat last week

13 Jun 2019, 1:06 pm

A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]

IPKat - http://ipkitten.blogspot.com/

Never Too Late: If you missed the IPKat last week

26 May 2019, 2:13 pm

A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]

IPKat - http://ipkitten.blogspot.com/

Never Too Late: If you missed the IPKat last week!

24 May 2019, 8:38 am

, Inc v Jen, Chi [2019] SGIPOS 3. [read post]

IPKat - http://ipkitten.blogspot.com/

Forest Laboratories, LLC v. Sigmapharm Laboratories, LLC (Fed. Cir. 2019)

31 Mar 2019, 7:48 pm by Patent Docs

Actavis Laboratories FL, Inc.). [read post]

Patent Docs - http://www.patentdocs.org/

Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2018)

26 Nov 2018, 9:58 pm by Patent Docs

By Kevin E. [read post]

Patent Docs - http://www.patentdocs.org/

Validity of Gilead’s Swiss TRUVADA® SPC confirmed but Switzerland will move away from the “infringement test” for future SPCs for combination products

20 Jun 2018, 4:12 am by Simon Holzer

On 3 January 2017 Mepha Pharma AG, a Swiss subsidiary of Teva, filed a revocation action against Gilead’s Swiss SPC. [read post]

Kluwer Patent Blog - http://patentblog.kluweriplaw.com/

United States Judicial Panel on Multidistrict Litigation: November Meeting Overview

30 Nov 2017, 8:59 pm by Brenda Fulmer

Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]

Searcy Mass Tort - https://searcymasstort.com/recent-news/

A Roadmap For CGL Insurers To Disclaim Defense and Indemnity For Underlying Opioid Litigation

13 Nov 2017, 7:00 am by CJ Haddick

Actavis, Inc., 2017 Cal. [read post]

Badfaithadvisor.com - https://badfaithadvisor.com

Judge Sleet Invalidates Patents-in-Suit After Finding of Obviousness and Enters Judgment in Favor of Alleged Infringer in Hatch-Waxman Action

9 Sep 2017, 5:56 am by Gregory B. Williams

Sleet in Tris Pharma, Inc. v. [read post]

Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/

Big Pharma Faces More Pay-for-Delay Fallout

27 Aug 2017, 10:01 pm by Barry Barnett

Actavis, Inc. [read post]